期刊文献+

PVP与放疗联合唑来膦酸治疗多节段胸腰椎转移瘤的疗效分析

The Clinical Efficacy of Percutaneous Vertebroplasty and Radiotherapy combined with Zoledronie Acid for the Treatment of Multiple Thoracolumbar Metastases
下载PDF
导出
摘要 目的:回顾性分析经皮椎体成形术与放疗联合唑来膦酸治疗多节段胸腰椎转移瘤的临床疗效。方法:随访自2011年6月~2016年6月我院因椎体转移瘤接受经PVP或放疗并联合唑来膦酸治疗的患者共104例,按照治疗方案,分为PVP组:PVP+唑来膦酸,共54例;放疗组:放疗+唑来膦酸,共50例,比较2组患者治疗前后症状改善情况、椎体形态及不良反应发生率。结果:治疗后3天PVP组VAS、EORTC评分较治疗前明显下降(P〈0.05),优于放疗组(P〈0.05)。6个月时2组疗效有显着差异(P〈0.05)。PVP组治疗后各时间点椎体相对高度与术前比较差异无统计学意义(P〉0.05),而放疗组6个月复查时见患椎高度明显丢失(P〈0.05)。2组不良反应症状均较轻,经对症治疗后均消失。结论:PVP与放疗联合唑来膦酸治疗多节段转移瘤,均可有效缓解疼痛,提高生活质量;PVP较放疗起效快,有效维持患椎高度,但需注意骨水泥渗漏压迫神经及穿刺风险;放疗则费用低,更方便,直接杀灭肿瘤细胞,但副反应较常见。 Objectiv:To review and analyze the clinical efficacy of pereutaneous vertebroplasty and radiotherapy combined with zole- dronie acid for the treatment of multiple thoracolumbar metastases. Methods:Follow - up 104 patients suffering from multiple thoracolum- bar metastases that were treated with percutaneous vertebroplasty or radiotherapy combined with zoledronie acid in our hospital From Jun 2011 to Jun 2016. According to the treatment, all patients were divided into two groups, PVP group had 54 patients and radiotherapy group had 50 patients. All patients'pain scale, quality of life, morphology change of vertebral and complication were observed. Processed the gained data in a statistical way and analyzed the clinical efficacy of different groups. Results: Compared with preoperative score, the scores of VAS and EORTC of PVP group were significantly decreased after operation 3 days ( P 〈 0.05 ), and was better than radiotherapy group(P 〈0.05). Each time after treatment, he score of life quality and pain of two groups were significantly lower than those before treatment. And 6 months after the treatment, the efficacy between two groups had significant difference( P 〈 0.05 ). And the height of the vertebral body( anterior,median and posterior) in PVP group had no obvious change too( P 〉0.05 ). However, after treatment 6 months, the height in radiotherapy had lost significantly compared with preoperative time and PVP group ( P 〈 0.05 ) . Tow groups also have letter complication, all disappeared after treatment. Conclusion: Percutaneous vertebroplasty and radiotherapy combined with zoledronie acid are also safe and effective treatment in improving the quality of life and pain relief. PVPg efficacy is faster and its ability of height maintain is better than radiotherapy. However, it needs to prevent nerve damage which caused by puncture and bone cement leakage. Radiotherapy is more convenient and cheaper; It can also kill tumor cells. But it has many side reactions.
作者 张贤俊 赵锡江 杨小奇 范强 ZHANG Xian -jun, ZHAO Xi -jiang, YANG Xiao - qi(Department of Orthopaedics, affiliated hospital, Jiangnan university. Wuxi, Jiangsu 21406)
出处 《中国伤残医学》 2018年第9期1-3,共3页 Chinese Journal of Trauma and Disability Medicine
关键词 经皮椎体成形术 放射治疗 唑来膦酸 肿瘤 Pereutaneous vertebroplasty Radiotherapy Zoledronie acid Tumor
  • 相关文献

参考文献5

二级参考文献98

  • 1申戈,宋三泰,江泽飞,卞寿庚,谢广茹,王雅杰,王杰军.唑来磷酸治疗恶性肿瘤引起高钙血症的临床研究[J].中华肿瘤杂志,2005,27(10):632-634. 被引量:18
  • 2董梅,冯奉仪.双膦酸盐治疗恶性肿瘤骨转移的基础研究与临床实践[J].癌症进展,2006,4(4):366-369. 被引量:8
  • 3彭六保,崔巍.唑来膦酸的临床应用研究进展[J].中国新药与临床杂志,2007,26(3):237-240. 被引量:36
  • 4蔡槱伯.脊柱转移性肿瘤的诊断与治疗[J].中国医刊,2007,42(4):2-4. 被引量:3
  • 5Rosen LS, Gordon D, Tchekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase Ⅲ, double-blind, randomized trial- the Zoledronic Acid Lung Cancer and Other Solid Tumor Study Group. J Clin Oncol, 2003, 21:3150- 3157.
  • 6李同度.癌痛的评估//张天泽,徐光炜.肿瘤学.天津:天津科学技术出版社,1996:2727-2730.
  • 7王华庆.附录//张天泽,徐光炜.肿瘤学.天津:天津科学技术出版社,1996:2766-2772.
  • 8Tyrrell CJ. Role of pamidronate in the management of bone metastases from breast cancer: results of a non-comparative multicenter phase Ⅱ trial. Ann Oncol, 1994, 5:S37-40.
  • 9Skerjanec A, Berenson J, Hsu C, et al. The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function. J Clin pharmacol, 2003, 43 : 154-162.
  • 10Body JJ, Lortholary A, Romieu G, et al. A dose-finding study of zoledronate in hypercalcemic cancer patients. J Bone Miner Res, 1999, 14:1557-1561.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部